TABLE 5.

Frequency and results of the complementary test at follow-up.

Alternative causes in the causality assessment at the time of report		The complementary test reinforced the association at follow-up		Re-exposition to the suspected drug
	n (%)		n (%)	n (%)
No enough information to ruled out another cause	113 (38.3)	Yes	12 (10.6)	4 (33.3)
		No (another cause more plausible)	5 (4.4)	1 (20.0)
		Inconclusive	72 (63.7)	16 (22.2)
		Not performed	24 (21.2)	7 (29.2)
Another cause was also possible	138 (46.8)	Yes	30 (21.7)	8 (26.7)
		No (another cause more plausible)	8 (5.8)	2 (25.0)
		Inconclusive	81 (58.7)	11 (13.6)
		Not performed	19 (13.8)	4 (21.1)
Alternative causes were ruled out in the causality assessment	44 (14.9)	Yes	12 (27.3)	0 (0.0)
		No (another cause more plausible)	0 (0)	0 (0.0)
		Inconclusive	24 (54.5)	7 (29.2)
		Not performed	8 (18.2)	2 (25.0)